Connect with us

Technology

Slone Partners Places Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences

Published

on

Industry veteran brings more than 25 years of experience in senior leadership roles

SOUTH RIDING, Va., May 29, 2024 /PRNewswire-PRWeb/ — Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Kevin Eastwood as Chief Business Officer at Arpeggio Biosciences, a preclinical therapeutics company whose technology targets transcriptional dysregulation in disease.

Kevin Eastwood is a highly accomplished and dynamic business leader with extraordinary passion and vision and a track record of success,” said Leslie Loveless, CEO and Managing Partner at Slone Partners.

Eastwood has more than 25 years of experience in senior leadership roles at innovative pharmaceutical and therapeutics companies across the nation. Most recently he served as Executive Vice President, Corporate Development at Plexium, Inc., where he helped secure a $35M series A-2 financing and $102M series B financing and established two multi-target, multi-year drug discovery collaborations, one with Amgen in the oncology disease area and a second with AbbVie in neuroscience. In prior roles, Eastwood served as Vice President, Corporate Development at the California Institute for Biomedical Research and the Scripps Research Institute; Senior Director, Corporate Development, Gilead Sciences, Inc.; and Startup Founder and Senior Vice President, Corporate Development, Effector Therapeutics, Inc.

Kevin Eastwood is a highly accomplished and dynamic business leader with extraordinary passion and vision and a track record of success,” said Leslie Loveless, CEO and Managing Partner at Slone Partners. “He brings a high level of strategic management and business development to the outstanding leadership team at Arpeggio.”

“We are thrilled to join forces with Kevin. With over 20 years of experience in business development, at Gilead and platform technology companies like Plexium and Ambrx, Kevin is the ideal person to elevate our functional genomics approach to targeting transcription factors to new heights,” said Joey Azofeifa, CEO at Arpeggio.

“I am grateful for the opportunity to join Arpeggio Biosciences to support its mission to transform the discovery of therapeutics that correct dysregulated transcription,” Eastwood stated. “Arpeggio’s HTS transcriptomics platform GRETA™ provides a novel approach for identifying small molecule transcription modulators, providing an opportunity to drug transcription factors, historically viewed as undruggable targets.”

Eastwood earned his B.S. in biology/chemistry from Missouri State University.

ABOUT SLONE PARTNERS
Founded in 2000, Slone Partners is a premier nationwide executive search firm that delivers visionary leaders who build amazing life sciences and healthcare organizations. With a nationwide presence in the most active industry hubs, we specialize in discovering and placing world-class Board, C-Suite leadership, and upper management talent with experience, conviction, and cultural competence in emerging and well-established companies. Our portfolio of executive search and advisory services includes customized cultural solutions through strategic planning, education, training, and coaching. Slone Partners proudly holds the designation as a Certified LGBT Business Enterprise™ by the National Gay & Lesbian Chamber of Commerce (NGLCC) and has earned recognition as a Top Executive Search Firm and a Top 20 Diversity and Inclusion Services firm by Manage HR. To learn more about Slone Partners’ value proposition and processes, visit https://www.slonepartners.com or call 888.784.3422.

ABOUT ARPEGGIO BIOSCIENCES
Arpeggio Biosciences is drugging transcription factors using AI and rapid RNA-sequencing. Powered by laboratory automation, Arpeggio discovers drugs based on not just a single target, but the entire cellular network. Arpeggio is currently progressing drug programs towards clinical studies in oncology and chronic kidney disease. To learn more, visit http://www.arpeggiobio.com.

Media Contact

Doug Gavel, Doug Gavel Communications, (617) 429-4417, doug.gavel@gmail.com, http://www.douggavel.com

View original content to download multimedia:https://www.prweb.com/releases/slone-partners-places-kevin-eastwood-as-chief-business-officer-at-arpeggio-biosciences-302157157.html

SOURCE Slone Partners

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

PEAK6 to Relocate Global Headquarters to Austin, Texas

Published

on

By

CHICAGO, Dec. 27, 2024 /PRNewswire/ — PEAK6 Investments LLC (“PEAK6”) today announced that, effective January 1, 2025, it will move its global headquarters from its current location in Chicago, Illinois to the company’s existing office in Austin, Texas, which it established in 2021. PEAK6 affiliates PEAK6 Group LLC, PEAK6 Strategic Capital LLC, PEAK6 APX Holdings LLC and PEAK6 LLC will also relocate their global headquarters to Austin. PEAK6 will maintain its office in Chicago.

Texas has been a cornerstone of PEAK6’s growth for over a decade,” said PEAK6 Co-Founder and Co-CEO, Matt Hulsizer, who continued, “With the majority of our talented workforce now based in Texas and Austin emerging as our largest office, moving our headquarters was an important decision to be closer to our team. We’re excited for the next chapter of PEAK6 that will be written from our new headquarters.”

Austin’s unique blend of creativity, technology and culture provides the ideal environment for PEAK6. The city’s highly educated workforce, business climate, and strong entrepreneurial spirit have enabled us to attract top talent and drive innovation.

About PEAK6

PEAK6 uses technology to find a better way of doing things. The company’s first tech-based solution was developed in 1997 to optimize options trading, and over the past two decades, the same formula has been used across a range of industries, asset classes, and business stages to consistently deliver superior results. Today, PEAK6 seeks transformational opportunities to provide capital and strategic support to entrepreneurs and forward-thinking businesses.

PEAK6’s core brands include PEAK6 Capital Management, PEAK6 Strategic Capital, Apex Fintech Solutions, We Insure, FOCUS, Zogo, Evil Geniuses and Poker Power.

View original content to download multimedia:https://www.prnewswire.com/news-releases/peak6-to-relocate-global-headquarters-to-austin-texas-302339437.html

SOURCE PEAK6 Investments

Continue Reading

Technology

Zero Zero Robotics showcases bestselling HOVERAir X1 series at CES 2025

Published

on

By

Redefining motion capture with innovative flying action cameras and the award-winning HOVERAir Beacon

LAS VEGAS, Dec. 27, 2024 /PRNewswire/ — Recently, Zero Zero Robotics, a pioneering tech company in intelligent devices, announced their participation at CES 2025, where the company will showcase its HOVERAir X1 series of self-flying cameras at booth # 56045, Venetian, Level 2, Halls A-D. Designed to simplify aerial cinematography, the HOVERAir lineup includes the pocket-sized HOVERAir X1, the action-focused HOVERAir X1 PRO, and the Professional grade HOVERAir X1 PROMAX. Zero Zero will also celebrate its 2025 CES Innovation Awards Honoree title in Audio/Video Components & Accessories for the HOVERAir Beacon, an intelligent modular controller that redefines precision tracking and control.

The introductory model in the HOVERAir lineup, HOVERAir X1, weighs just 125g and delivers an effortless aerial photography experience with no controller or app required. With over five pre-programmed flight paths, including Hover, Follow, Zoom Out, Orbit, and Bird’s Eye, it’s perfect for capturing cinematic moments in everyday life. Its 2.7K video resolution, palm launch capabilities, and robust computer vision algorithms make it the ultimate everyday and travel companion.

Building on the success of the X1, Zero Zero introduced the HOVERAir X1 PRO and HOVERAir X1 PROMAX in August 2024 to meet the demands of action enthusiasts and professional creators. The X1 PRO offers 4K/60fps video with a 104° field of view for versatile shooting conditions. The X1 PROMAX delivers stunning 8K/30fps video with 4K/120fps slow-motion capabilities, a 1/1.3″ CMOS sensor, and 14 stops of dynamic range for cinematic footage. Both models feature advanced AI tracking, Level 5 wind resistance, and a lightweight, durable HEM™ frame.

“Our vision has always been to create flying cameras that are effortless, intelligent, and fun to use,” said MQ Wang, Founder & CEO of Zero Zero Robotics. “The HOVERAir series puts professional-grade aerial cinematography in the palm of your hand, whether you’re capturing casual moments or pushing creative boundaries.”

Adding to these innovations, the HOVERAir Beacon enhances control and precision for the series. The Beacon features a patented Tri-state modular design with two detachable joysticks, enabling one-handed and full-featured two-handed controls. It activates HoverLink™ for precise tracking with up to a 1 km transmission range, while the 1.78″ OLED display allows real-time footage monitoring. Equipped with AI-powered noise cancellation, the Beacon sets a new standard for audio and video recording during aerial shoots.

“We’re excited to bring the HOVERAir X1 series and Beacon to CES 2025, where we’re redefining how motion is captured, tracked, and controlled,” continued Wang. “These tools empower creators and adventurers to document their journeys with breathtaking precision and ease.”

Zero Zero Robotics invites attendees to stop by Booth #56045 to experience the HOVERAir X1 series in action and witness its unparalleled performance. Media wishing to interview Zero Zero Robotics personnel should contact Borjana Slipicevic.

About Zero Zero Robotics

Zero Zero Robotics was co-founded in 2014 by Stanford PhDs MQ Wang and Tony Zhang, specializing in embedded AI technology for intelligent devices. Known for its innovative machine vision and high-precision control systems, ZeroZero has team members who are dreamers, engineers, inventors, and builders hailing from top universities and research institutions around the world. Zero Zero Robotics holds more than 140 core patents and has pioneered technologies like fully enclosed portable propeller designs and bi-copter designs, cementing its place as a leader in intelligent device development.

Photo – https://mma.prnewswire.com/media/2587719/20241225_CES.jpg

View original content:https://www.prnewswire.co.uk/news-releases/zero-zero-robotics-showcases-bestselling-hoverair-x1-series-at-ces-2025-302339226.html

Continue Reading

Technology

ResumeTemplates.com Survey Reveals 3 in 10 Gen Zers Believe CEOs Are Evil; Many Support Release of Mangione

Published

on

By

The majority of Gen Zers feel CEOs wield excessive power, with some expressing extreme views about corporate accountability

SEATTLE, Dec. 27, 2024 /PRNewswire-PRWeb/ — ResumeTemplates.com, the leading platform for professional resume templates and career advice, has released findings from a recent survey revealing critical attitudes among Gen Z toward corporate leaders. Conducted in December 2024, the survey of 1,200 U.S.-based Gen Zers highlights the sentiment that CEOs hold excessive power and are overcompensated, with some respondents expressing extreme views about corporate accountability.

According to the survey, more than half of Gen Zers (55%) believe CEOs wield excessive power in society, particularly influencing elections, the economy, and policymaking. Additionally, 59% of respondents believe CEOs are overpaid, with most saying total annual compensation should not exceed $750,000. Only 7% of respondents support unlimited earning potential for CEOs. The survey also found that 39% of Gen Zers believe all levels of a workforce equally contribute to a company’s success, while only 20% think CEOs create the most value within an organization.

The survey also explored Gen Z’s perceptions of corporate leadership. More than half believe CEOs are responsible for driving corporate greed, and 30% of respondents view CEOs as “evil,” reflecting deep skepticism toward corporate leadership.

Additionally, the survey examined opinions on high-profile cases like Brian Thompson’s killing. Among respondents, 21% agreed that “CEOs deserve to lose their lives for their professional actions,” including 7% who strongly agreed. When asked specifically about Brian Thompson’s killing, 22% of respondents believe he definitely (10%) or probably (12%) deserved what happened to him. Regarding Luigi Mangione, Thompson’s accused killer, 21% supported his release, while 51% opposed it.

This survey, conducted December 18, 2024, via Pollfish, gathered responses from 1,200 U.S.-based 18 to 27 year olds. The full report can be viewed here: https://www.resumetemplates.com/3-in-10-gen-zers-say-ceos-are-evil-many-believe-mangione-should-go-free/

ABOUT RESUMETEMPLATES.COM
ResumeTemplates.com offers a comprehensive selection of free, industry-specific resume templates, tailored to meet the needs of various job seekers. The website also provides extensive resources to help facilitate the job application process, including expert advice, resume examples, and tips and tricks for creating impactful resumes. For more information, please visit: https://www.resumetemplates.com/.

Media Contact

Abigail Davis, ResumeTemplates, 000-0000, abigail@resumetemplates.com

View original content:https://www.prweb.com/releases/resumetemplatescom-survey-reveals-3-in-10-gen-zers-believe-ceos-are-evil-many-support-release-of-mangione-302338434.html

SOURCE ResumeTemplates

Continue Reading

Trending